Patent details

Basic Information

Publication number:

EP2170390

PCT Application Number:

US2008066928

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP087710265

PCT Publication Number:

WO2008157356

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

NATALIZUMAB ANTIBODY FORMULATIONS

French Title of Invention:

FORMULATIONS D'ANTICORPS NATALIZUMAB

German Title of Invention:

NATALIZUMAB-ANTIKÖRPER-FORMULIERUNGEN

SPC Number:

Dates

Filing date:

13/06/2008

Grant date:

07/11/2018

EP Publication Date:

07/04/2010

PCT Publication Date:

24/12/2008

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

07/11/2018

EP B1 Publication Date:

07/11/2018

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

13/06/2028

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

31/10/2018

 

 

Name:

BIOGEN MA INC.

Address:

225 Binney Street, Cambridge, MA 02142, United States (US)

Agent

Name:

STOLMÁR & PARTNER

From:

01/02/2019

Address:

BLUMENSTR. 17, 80331, MÜNCHEN, Germany (DE)

To:

Inventor

Name:

MALONEY, Kevin

Address:

United States (US)

Priority

Priority Number:

944076 P

Priority Date:

14/06/2007

Priority Country:

United States (US)

Classification

IPC classification:

A61K 39/395; C07K 16/28;

Publication

European Patent Bulletin

Issue number:

201845

Publication date:

07/11/2018

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

30/06/2026

Annual Fee Number:

19

Annual Fee Amount:

281 Euro

Expected Payer:

Last Annual Fee Payment Date:

23/05/2025

Last Annual Fee Paid Number:

18

Last Annual Fee Paid Amount:

262 Euro

Payer:

ANAQUA SERVICES (ANC. SGA2)

Filing date	Document type	Number of pages
18/02/2019	Outgoing Correspondence	1
01/02/2019	Power Of Attorney	2